Alzheimer’s Disease Biomarkers Market Predicted to Reach USD 1.7 billion by 2031, Expanding at a 7.5% CAGR Says, Transparency Market Research Inc.
14 août 2023 07h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Alzheimer’s disease biomarkers market is expected to be valued at US$ 953.54...
Oncore Pharma Signs a Multi-Year Agreement Valued at $61.8 Million
10 oct. 2019 10h49 HE
|
Oncore Pharma
Cambridge MA, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oncore Pharma Inc., a life sciences company specializing in blood-based biomarker tests for early cancer detection, announced...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21 juil. 2016 08h30 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Research Collaboration With Johnson & Johnson Innovation
11 janv. 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - January 11, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests, announced today that it has entered into a research...
DiamiR Announces Formation of Advisory Board
07 janv. 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - January 07, 2016) - DiamiR Biosciences, a developer of innovative minimally invasive diagnostic tests for early detection and monitoring of neurodegenerative...
DiamiR Announces Corporate Presentation at Life Sciences Summit 2014
22 oct. 2014 08h02 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - October 22, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...